Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAC Chemotherapy plus Activated T Cells in High-Risk Breast Cancer
NCT00022230Phase 2Withdrawn
- Sponsor
- Roger Williams Medical Center
- Start
- Jan 2000
- Primary completion
- Jan 2007
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic autologous lymphocytes in breast cancer, sponsored by Roger Williams Medical Center. Planned start Jan 2000; status: withdrawn.
02
Drugs
therapeutic autologous lymphocytes
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00022230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022230.